Summarized by Masters of Longevity from MedTech Dive.
Natera named long-time executive Solomon Moshkevich as CEO and director.
Key Takeaways
- Moshkevich has led development of Natera's cell-free DNA tests.
- The promotion is intended to provide continuity after Chapman's exit.
- The company reported 34.1% revenue growth amid a stock drop.